Keynote Presentation
HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.
Campanile Roissy-en-France Hotel
Roissy Park Activity Area - Allee Des Vergers 95700 Roissy in France
Paris, France
Scientific Program
Keynote Presentation
Keynote Presentation
COPD heterogeneity: Eosinophilic COPD is similar to asthma?
Pier Luigi Paggiaro, University of Pisa, Italy
Updated soon...
Poster Presentation
Spirometry follow up for patients with diagnosis of Chronic Obstructive Pulmonary Disease
Manoj Marathe, Russells Hall Hospital, United Kingdom
Introduction: Although it is well established that a diagnosis of Chronic Obstructive Pulmonary Disease (COPD) must include accurate spirometry, the evidence for the reliability of inpatient spirometry is mixed. If inpatient spirometry is performed, it is suggested that a follow [....]
Poster Presentation
Sociodemographic and Clinical Characteristics of Patients with Severe Exacerbation of COPD. Are There Sex Differences?
katherine Centeno Hurtado, Industrial University of Santander, Columbia
RATIONALE: COPD exacerbations (AECOPD) are the main determinant of morbidity and mortality in the disease. However, studies on their prevalence and characterization are scarce in Latin America and virtually nonexistent in Colombia; additionally, the existence of sex-related [....]
Poster Presentation
A service improvement: Is implementing combined compound exercises more beneficial than isolation exercises for patients with chronic respiratory disease in a pulmonary rehabilitation programme?
Elizabeth Ashley Aitcheson, Liverpool Heart and Chest Hospital, United Kingdom
Chronic Obstructive Pulmonary Disease (COPD) is the second most common lung disease in the UK, characterised by ventilator obstructions resulting in airflow limitation and potential mucosal retention. It is one of the major causes of morbidity and mortality with an estimated annu [....]
Poster Presentation
Prevalence of Human Immunodeficiency Virus Infection among Tuberculosis Patients in Nepal
Badri Nath Jnawali, National TB Centre, India
Rational: National Tuberculosis Program has envisioned to provide human immunodeficiency virus testing for all tuberculosis patients. However, human immunodeficiency virus testing coverage among notified tuberculosis patients is very low in Nepal. Similarly, the prevalence of HIV [....]
Poster Presentation
Plasmapheresis in Asthma
Valerii A. Voinov, Pavlov First Saint Petersburg State Medical University, Russia
In recent years there has been a continuous increase in the frequency of allergic diseases with damage of skin, mucous of the upper respiratory tract and bronchi. Increased incidence of allergic diseases (up to 20% of the population) is the result of human contact with the g [....]
Poster Presentation
Estimating the economic burden associated in the treatment of community acquired pneumonia (CAP) among adults with chronic obstructive pulmonary disease (COPD) in Ireland
Simon Walsh, Pfizer Healthcare Ireland, Ireland
The economic burden of COPD is substantial. In the EU, the burden of COPD is estimated at €48.4 billion annually (1). In CAP treatment, COPD is associated with increased healthcare resource use and medical costs (2). Projected population growth and aging will require investm [....]
Poster Presentation
The correlation between electric cigarettes users and vital capacity between students at Universitas Islam Indonesia
Radenroro Parasthity Niwangsari, Universitas Islam Indonesia, Indonesia
Background: Smoking can cause damage at various types of organs in the body, including the lungs. Smoking can cause a variety of chronic diseases in the lungs such as pneumonia, emphysema and also restrictive lung disease. In ecigarettes there are harmful substances that can caus [....]
Osteonecrosis of the maxilla and mandible
Allen Fred Fielding, Temple University, USA
There is much controversy of the treatment of patients taking bisphosphonates and the resultant problem of ONJ (Osteonecrosis of the Jaw). The name changes from BRONJ to ASONJ to MRONJ to DRONJ beginning in 2003 shows how the development of what has now led up to 2020 treatment r [....]
COPD and workplace
Jordan Minov, Institute for Occupational Health of R. North Macedonia, R. North Macedonia
Chronic obstructive pulmonary disease (COPD) is a major cause of disability and one of the leading causes of death throughout the world. Although the cigarette smoking is the major and the best studied causative factor of COPD, there is consistent evidence that [....]
Radiation Pneumonitis Following Definitive Therapy with Radiation, Chemotherapy, and Immunotherapy
Rodney E. Wegner, Allegheny Health Network Cancer Institute, USA
Non small cell lung cancer (NSCLC) remains one of the most common and lethal malignancies across the world, often affecting smokers who have other comorbid conditions which can limit the ability to receive adequate treatment. The current standard of care for stage IIIB NSCLC rema [....]
The role of basophils in the pathogenesis of COPD
Sho Shibata, Department of Respiratory Medicine, Japan
Chronic obstructive pulmonary disease (COPD) is estimated to affect 174.5 million persons in the global population and is the fourth leading cause of death in the world. It has been generally considered as a non-Th2-type lung disorder, characterized by progressive airflow limitat [....]
Grape seed proanthocyanidin extract ameliorates glucocorticoid insensitivity in severe asthma
Qian Zhang, Nanjing Medical University, China
Objective: To explore the role and mechanism of grape seed proanthocyanidin extract (GSPE) in the regulation of glucocorticoid sensitivity in a mouse model of asthma and peripheral blood mononuclear cells (PBMCs) of severe asthmatic patients. Methods: We recruited 20 healthy con [....]
FEV1 / FEV6 microspirometry – as a screening tool for chronic obstructive pulmonary disease.
Jayesh Srivastava, Sarojini Naidu Medical College, India
Background: Various studies in India have found that the prevalence of undiagnosed COPD is between 4 to 18.2 %. The microspirometry, which is based on measurements FEV1 (forced expiratory volume in 1 second), [....]
The Role of Patients Education in the Management of Asthma/COPD
Irine Pkhakadze, Akaki Tsereteli State University, Georgia
The results of treatment of patients with asthma / COPD largely depends on the level of the patients` education and the need to use of the recommended management plan, besides the availability of health care services and medicines. The role of the patient's education is imp [....]
Activin-A protects against lung cancer progression by boosting anti-tumor T cell responses
Maria Semitekolou, Biomedical Research Foundation of the Academy of Athens, Greece
Activin-A is a pleiotropic cytokine that exerts diverse effects on immune responses depending on the spatiotemporal context; still its precise role in shaping anti-tumor T cell-mediated immune responses remains ill defined. In order to evaluate whether activin-A directs effect [....]
Long Term Results of Lung Volume Reduction Surgery
Bryan Payne Stanifer, Columbia University Medical Center, USA
COPD remains a leading cause of morbidity and mortality worldwide. For emphysema in particular, there are few effective treatments. The rediscovery and refinement of lung volume reduction surgery in the 1990’s let to the NETT trial in the early 2000’s. Des [....]
The use of stereotactic body radiation therapy in patients with severe COPD
Zachary D Horne, Allegheny Health Network Cancer Institute, USA
Non-small cell lung cancer (NSCLC) is one of the most common cancers worldwide and has a strong link to smoking, as does the development of COPD. Because of poor respiratory reserves, these patients are often not candidates for definitive surgery. SBRT represents an e [....]
Transcriptomic characterization of Chronic Obstructive Pulmonary Disease using PulmonDB
Ana Beatriz Villasenor Altamirano, UNAM-LIIGH, Mexico
Chronic Obstructive Pulmonary Disease (COPD) is the fourth worldwide cause of death and has been broadly studied given its medical relevance and its lack of consensus regarding its pathology and etiology. The development of technologies, such as microarrays and RNAseq, allows us [....]
Role of proton therapy in reducing risk of lung disease in lymphoma
Shaakir Hasan, New York Proton Center, USA
Several observational studies indicate that patients with lymphoma of the mediastinum, neck, or axilla are at increased risk for acute and late lung disease due to the cytoxic chemotherapy and radiation required to control the malignancy. This is particularly important for younge [....]
Lung Stereotactic Ablative Radiotherapy in Medically Inoperable Lung Cancer
Athanasios Colonias, Allegheny Health Network Cancer Institute, USA
The standard of care for the treatment of stage I non-small cell lung cancer (NSCLC) remains surgery. Often times, however, these patients are not surgical candidates due to coexisting comorbidities such as COPD and poor cardiopulmonary reserve. A viable alternative t [....]